Interleukin-6 is independently associated with right ventricular function in pulmonary arterial hypertension (scientific article published in September 2017)

Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility

Q28574235

Relationship of interleukin-6 with regional and global left-ventricular function in asymptomatic individuals without clinical cardiovascular disease: insights from the Multi-Ethnic Study of Atherosclerosis

Q33764598

Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension

Q33898213

Pulmonary arterial hypertension in France: results from a national registry

Q33993302

Protein changes contributing to right ventricular cardiomyocyte diastolic dysfunction in pulmonary arterial hypertension

Q35021804

Echocardiographic predictors of mortality in patients with pulmonary hypertension and cardiopulmonary comorbidities.

Q35182424

Interleukin-6 and tumor necrosis factor-α are associated with quality of life-related symptoms in pulmonary arterial hypertension

Q35565086

Right heart dysfunction in heart failure with preserved ejection fraction

Q35588220

Sildenafil prevents and reverses transverse-tubule remodeling and Ca(2+) handling dysfunction in right ventricle failure induced by pulmonary artery hypertension.

Q35699243

Differential calcium handling in two canine models of right ventricular pressure overload

Q36198962

Deletion of interleukin-6 alleviated interstitial fibrosis in streptozotocin-induced diabetic cardiomyopathy of mice through affecting TGFβ1 and miR-29 pathways

Q36681664

Deletion of Interleukin-6 Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy and Dysfunction

Q36994116

Relationship of CRP, IL-6, and fibrinogen with right ventricular structure and function: the MESA-Right Ventricle Study

Q37248994

Pulmonary pulse wave transit time is associated with right ventricular-pulmonary artery coupling in pulmonary arterial hypertension.

Q37555462

Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).

Q38372331

Enhanced pulmonary vasodilator reserve and abnormal right ventricular: pulmonary artery coupling in heart failure with preserved ejection fraction

Q38413616

Interleukin-6 overexpression induces pulmonary hypertension

Q41056520

Hypoxic stress induces cardiac myocyte-derived interleukin-6.

Q41363376

Leukemia Inhibitory Factor and Interleukin-6 downregulate sarcoplasmic reticulum Ca2+ ATPase (SERCA2) in cardiac myocytes

Q41728755

Mechanical load-dependent regulation of gene expression in monocrotaline-induced right ventricular hypertrophy in the rat.

Q42169450

Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice

Q42273111

Tricuspid annular displacement predicts survival in pulmonary hypertension

Q44026625

Plasma interleukin-6 adds prognostic information in pulmonary arterial hypertension

Q44453474

Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy

Q44682915

Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease

Q44780252

Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle

Q44805539

The interleukin-6/interleukin-6-receptor system is activated in donor hearts

Q48617732

Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure: an index of right ventricular contractile function and prognosis.

Q49085974

Nitric oxide-mediated effects of interleukin-6 on [Ca2+]i and cell contraction in cultured chick ventricular myocytes.

Q50770745

Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation.

Q51764417

RV Contractile Function and its Coupling to Pulmonary Circulation in Heart Failure With Preserved Ejection Fraction: Stratification of Clinical Phenotypes and Outcomes.

Q52680478

Echocardiography of Right Ventriculoarterial Coupling Combined With Cardiopulmonary Exercise Testing to Predict Outcome in Heart Failure.

Q53326153

Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension.

Q54504564

Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension

Q57148895

Prognostic relevance of the echocardiographic assessment of right ventricular function in patients with idiopathic pulmonary arterial hypertension

Q57786248

Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)

Q59192167

Negative inotropic effects of cytokines on the heart mediated by nitric oxide

Q68208763

The estimation of oxygen consumption

Q71427855

Pulmonary hypertension in rats. 2. Role of interleukin-6

Q71791536

Activation of the cardiac interleukin-6 system in advanced heart failure

Q74394356

Monocrotaline induces interleukin-6 mRNA expression in rat lungs

Q77224638

Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle

Q79830429

Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension

Q82601602

Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

Q86455840

P433

issue

P304

page(s)

376-384

P577

publication date

2017-09-01

P1433

published in

The Journal of Heart and Lung Transplantation

Q2364382

P1476

title

Interleukin-6 is independently associated with right ventricular function in pulmonary arterial hypertension

P478

volume

Reverse relations

cites work (P2860)

Q90436104	Activation of the Metabolic Master Regulator PPARγ: A Potential PIOneering Therapy for Pulmonary Arterial Hypertension
Q92670725	Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker?
Q90159557	Association of Mild Echocardiographic Pulmonary Hypertension With Mortality and Right Ventricular Function
Q60363740	Classical IL-6 signaling: a promising therapeutic target for pulmonary arterial hypertension
Q92932841	Clonally selected primitive endothelial cells promote occlusive pulmonary arteriopathy and severe pulmonary hypertension in rats exposed to chronic hypoxia
Q97524662	In the eye of the storm: the right ventricle in COVID-19
Q55155611	Inflammatory Mediators Drive Adverse Right Ventricular Remodeling and Dysfunction and Serve as Potential Biomarkers.
Q90166128	Plasma concentration and expression of adipokines in epicardial and subcutaneous adipose tissue are associated with impaired left ventricular filling pattern
Q58745332	Transcriptomic Signature of Right Ventricular Failure in Experimental Pulmonary Arterial Hypertension: Deep Sequencing Demonstrates Mitochondrial, Fibrotic, Inflammatory and Angiogenic Abnormalities
Q89996893	Validation of the Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio for the Assessment of Right Ventricular-Arterial Coupling in Severe Pulmonary Hypertension

P356	DOI	10.1016/J.HEALUN.2017.08.011
P8608	Fatcat ID	release_5oz52s2gzze4fm44qp2js5hwc4
P932	PMC publication ID	5854490
P698	PubMed publication ID	28893516